Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of RGC will decline by -22.70% over the next 2 Weeks and hit $10.80 by Friday, August 22, 2025. In that time frame, RGC's share price is expected to range between $6.18 and $15.19.
BearishAverageBullishRGC shares rose +5.99% in Friday, August 8, 2025's trading session, rising from a previous close of $13.18 to move at $13.97. The stock demonstrated notable intraday movement (see RGC's key stats for a full breakdown), fluctuating between $13.30 and $14.10, a +6.01% trading range. While recent weeks have seen some volatility, RGC has managed to secure a +1.23% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 287.53K shares changing hands, 102.37K fewer than the previous session. This amounted to $4.02M in total market activity.
Will RGC Continue Its Upward Trend?
According to analyst ratings and projections for RGC, Regencell Bioscience Holdings Limited shares are anticipated to increase by +9.28%, potentially reaching $15.40 per share by August 22, 2025. Short-term technical indicators for RGC currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 20 negative trading days within the past 30 sessions. Based on the RGC stock forecast, now is a good time to buy RGC stock because its current trading price is +29.91% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on RGC covering social and institutional perspectives.
RGC Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into RGC's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 46.62% to 47.64%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 50.50%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 51.75%, maintains a neutral outlook for the long term. Insights into RGC's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Regencell Bioscience Short-Term Forecasts
RGC Forecast For Next 5 Days
Our algorithm anticipates Regencell Bioscience (RGC) stock could hit $35.53 by Aug 15, 2025. This represents a +154.30% rise from today's price, following a +7.71% change over the past five days.
RGC Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Regencell Bioscience Holdings Limited (RGC) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $15.55, which would mean a +11.31% increase from the current price of $13.97. Projections for this period range from a high of $47.54 to a low of -.
RGC Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Regencell Bioscience's price over the next three months point to a rise. RGC stock is expected to peak at $154.54 on Oct 28, 2025 after potentially dipping to $41.50 on Aug 11, 2025. On average, RGC is likely to trade around $90.58 in the coming 90 days.
Regencell Bioscience Stock Forecast 2025
Based on our predictive models, Regencell Bioscience (RGC) is expected to trade between $41.50 and $231.94 throughout 2025. This would result in an average price of $98.79, potentially offering investors a +607.16% return from current levels.
Regencell Bioscience Holdings Limited Monthly Forecast 2025–2026
August 2025
According to our latest forecast models, Regencell Bioscience Holdings Limited (RGC) is positioned to show a strong performance in August 2025. The price is predicted to move between $41.50 and $91.38, settling at an average of $64.95. This could translate to a +364.92% gain.
September 2025
Based on current market signals, Regencell Bioscience Holdings Limited is projected to trend september 2025. We forecast a trading range from $67.16 to $106.05, with a likely average price of $85.19. Investors could expect a potential return of +509.81%.
October 2025
Our predictive algorithms indicate Regencell Bioscience Holdings Limited stock may see a shift in October 2025. The expected range spans $91.24–$154.54, with an average target of $118.34. This represents a positive outlook and a possible gain of +747.10%.
November 2025
Analyzing established trends, Regencell Bioscience Holdings Limited looks set to move in November 2025. Projections place the stock between $42.31 and $231.94, averaging around $116.38. This suggests a +733.07% gain from current levels.
December 2025
Market indicators suggest Regencell Bioscience Holdings Limited could experience notable changes during December 2025. Prices could fluctuate within $70.09 to $115.20, with a midpoint forecast of $99.03. The stock might deliver a +608.88% gain.
January 2026
Forecasting for January 2026, models estimate that Regencell Bioscience Holdings Limited may undergo key fluctuations. If trends hold, the stock might trade between $60.23 and $122.62, averaging $94.94. This signals a positive trajectory with potential returns around +579.60%.
February 2026
According to our latest forecast models, Regencell Bioscience Holdings Limited (RGC) is positioned to show a strong performance in February 2026. The price is predicted to move between $45.06 and $99.63, settling at an average of $71.19. This could translate to a +409.59% gain.
March 2026
Based on current market signals, Regencell Bioscience Holdings Limited is projected to trend march 2026. We forecast a trading range from $41.90 to $105.34, with a likely average price of $71.42. Investors could expect a potential return of +411.24%.
April 2026
Our predictive algorithms indicate Regencell Bioscience Holdings Limited stock may see a shift in April 2026. The expected range spans $0.00–$156.72, with an average target of $45.52. This represents a positive outlook and a possible gain of +225.84%.
May 2026
Analyzing established trends, Regencell Bioscience Holdings Limited looks set to move in May 2026. Projections place the stock between $43.33 and $76.53, averaging around $60.30. This suggests a +331.64% gain from current levels.
June 2026
Market indicators suggest Regencell Bioscience Holdings Limited could experience notable changes during June 2026. Prices could fluctuate within $51.26 to $135.94, with a midpoint forecast of $100.35. The stock might deliver a +618.32% gain.
July 2026
Forecasting for July 2026, models estimate that Regencell Bioscience Holdings Limited may undergo key fluctuations. If trends hold, the stock might trade between $18.22 and $60.10, averaging $42.27. This signals a positive trajectory with potential returns around +202.58%.
August 2026
According to our latest forecast models, Regencell Bioscience Holdings Limited (RGC) is positioned to show a strong performance in August 2026. The price is predicted to move between $57.42 and $83.13, settling at an average of $71.94. This could translate to a +414.96% gain.
RGC's history of dividends and stock splits also plays a role in long-term investor confidence.